Company Changes its Stock Sale Plans: Advanced...

Company Changes its Stock Sale Plans: Advanced Interventional Systems Inc. announced Monday that it has revised its plans for an initial public stock offering and now plans to sell 2 million shares at between $10 and $12 per share. The Irvine company had announced an initial public offering of 2.1 million shares on Aug. 30, contingent on receiving Food and Drug Administration approval to market its excimer laser for coronary angioplasty, used to treat cardiovascular disease, AIS spokeswoman Connie McCluskey said. The company has decided to go forward with the stock offering although the FDA approval has not yet been received, McCluskey said. A prospectus for the offering is now available, but no date for the sale has been set, she said.